Clinical assessment of fluorescence cystoscopy during transurethral bladder resection in superficial bladder cancer (original) (raw)

Abstract

The prognosis of superficial bladder cancer in terms of recurrence and disease progression is related to bladder tumor multiplicity and the presence of concomitant “plane” tumors such as high-grade dysplasia and carcinoma in situ. This study in 33 patients aimed to demonstrate the role of fluorescence cystoscopy in transurethral resection of superficial bladder cancer. The method is based on the detection of protoporphyrin-IX-induced fluorescence in urothelial cancer cells by topical administration of 5-aminolevulinic acid. The sensitivity and the specificity of this procedure on apparently normal mucosa in superficial bladder cancer are estimated to be 82.9% and 81.3%, respectively. Thus, fluorescence cytoscopy is a simple and reliable method for mapping the bladder mucosa, especially in the case of multifocal bladder disease, and it facilitates the screening of occult dysplasia.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Olsen PR, Wolf H, Schroeder T, Fischer A, Hojgaard K (1988) Urothelial atypia and survival rate of 500 unselected patients with primary transitional-cell tumour of the urinary bladder. Scand J Urol Nephrol 22:257
    PubMed Google Scholar
  2. Witjes JA, Kiemeney LALM, Oosterhof GON, Debruyne FMJ (1992) Prognostic factors in superficial bladder cancer. Eur Urol 21:89
    PubMed Google Scholar
  3. Wolf H, Hojgaard K (1983) Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences. Lancet 8340:134
    Google Scholar
  4. Wallace DMA, Hindmarsh JR, Webb JN, Busuttil A, Hardgreave TB, Newsam JE, Chisholm GD (1979) The role of multiple mucosal biopsies in the management of patients with bladder cancer. Br J Urol 51:535
    PubMed Google Scholar
  5. Kiemeney LALM, Witjes JA, Heijbroek RP, Koper NP, Verbeek ALM, Debruyne FMJ and the Members of the Dutch South-East Co-operative Urological Group (1994) Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol 73:164
    PubMed Google Scholar
  6. Vicente J, Chéchile G, Algaba F (1987) Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol 13:15
    PubMed Google Scholar
  7. Benson RC, Farrow GM, Kinsey JH, Cortese DA, Zincke H, Utz DC (1982) Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc 57:548
    PubMed Google Scholar
  8. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B: Biol 6:143
    Google Scholar
  9. Kriegmair M, Baumgartner R, Knuechel R, Steinbach P, Ehsan A, Lumper W, Hofstädter F, Hofstetter A (1994) Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44:836
    PubMed Google Scholar
  10. Kriegmair M, Baumgartner R, Knuechel R, Stepp H, Hofstddter F, Hofstetter A (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155:105
    PubMed Google Scholar
  11. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnières G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ (in press) Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid. Preliminary results. Lasers Surg Med (in press)
  12. Mostofi FK, Sobin LH, Torloni H (1973) Histological typing of urinary bladder tumours. In: world Health Organisation (ed) International histological classification of tumours. WHO, Geneva
    Google Scholar
  13. UICC (1992) TNM classification of malignant tumours, 4th edn. Springer-Verlag, Berlin Heidelberg New York
    Google Scholar
  14. Nagy GK, Frable WJ, Murphy WM (1982) Classification of premalignant urothelial abnormalities. A Delphi study of the National Bladder Cancer Collaborative Group A. In: Sommers SC, Rosen PP (eds) Pathology Annual, Appleton-Century-Crofts, Norwalk, p 219
    Google Scholar
  15. Levi F, La Vecchia C, Randimbison L, Franceschi S (1993) Incidence of infiltrating cancer following superficial bladder carcinoma. Int J Cancer 55:419
    PubMed Google Scholar
  16. Abel PD (1993) Follow-up of patients with “superficial” transitional cell carcinoma of the bladder: the case for a change in policy. Br J Urol 72:135
    PubMed Google Scholar
  17. Klän R, Loy V, Huland H (1991) Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146:316
    PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital, CHUV, CH-1011, Lausanne, Switzerland
    P. Jichlinski, M. Oswald & H. J. Leisinger
  2. Laboratory of Environmental Engineering, Swiss Federal Institute of Technology (EPFL), CH-1015, Lausanne, Switzerland
    G. Wagnières, M. Forrer, J. Mizeret & H. Van den Bergh
  3. Institute of Pathology, University Hospital, CHUV, CH-1011, Lausanne, Switzerland
    L. Guillou
  4. Department of Urology, University Hospital, HCUG, CH-1205, Geneva, Switzerland
    F. Schmidlin & P. Graber

Authors

  1. P. Jichlinski
  2. G. Wagnières
  3. M. Forrer
  4. J. Mizeret
  5. L. Guillou
  6. M. Oswald
  7. F. Schmidlin
  8. P. Graber
  9. H. Van den Bergh
  10. H. J. Leisinger

Rights and permissions

About this article

Cite this article

Jichlinski, P., Wagnières, G., Forrer, M. et al. Clinical assessment of fluorescence cystoscopy during transurethral bladder resection in superficial bladder cancer.Urol. Res. 25 (Suppl 1), S3–S6 (1997). https://doi.org/10.1007/BF00942040

Download citation

Key words